ProCE Banner Activity

Aripiprazole: Long-Acting Injectable in Schizophrenia

Multimedia
This video discusses the use of aripiprazole long-acting injectable in the treatment of schizophrenia. Information on the 4-phase study is presented, along with findings on long-term efficacy, relapse rates, and adverse events.

Released: April 20, 2020

Expiration: April 19, 2021

No longer available for credit.

Share

Faculty

Prakash Masand

Prakash Masand, MD

Chief Medical Officer
Clinical Education Alliance
Adjunct Professor
Duke-NUS
New York, New York

Faculty Disclosure

Primary Author

Prakash Masand, MD

Chief Medical Officer
Clinical Education Alliance
Adjunct Professor
Duke-NUS
New York, New York